McDermott D - Search Results

1

Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.

Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J. Offit K, et al. Among authors: mcdermott d. Clin Cancer Res. 2002 Dec;8(12):3813-9. Clin Cancer Res. 2002. PMID: 12473594

2

Risk of endometrial carcinoma associated with BRCA mutation.

Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J. Levine DA, et al. Among authors: mcdermott d. Gynecol Oncol. 2001 Mar;80(3):395-8. doi: 10.1006/gyno.2000.6082. Gynecol Oncol. 2001. PMID: 11263938

3

The effect of surgical debulking on the response of patients with ovarian carcinoma to chemotherapy.

McDermott DF, Jaffe EA, Coleman M, Pasmantier MW. McDermott DF, et al. Am J Clin Oncol. 1988 Oct;11(5):520-3. doi: 10.1097/00000421-198810000-00002. Am J Clin Oncol. 1988. PMID: 3177252

4

COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma.

Boyd DB, Coleman M, Papish SW, Topilow A, Kopel SK, Bernhardt B, Files JC, Schwartz S, Gaynor M, McDermott D, et al. Boyd DB, et al. Among authors: mcdermott d. J Clin Oncol. 1988 Mar;6(3):425-33. doi: 10.1200/JCO.1988.6.3.425. J Clin Oncol. 1988. PMID: 2450970

5

The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.

Coleman M, Armitage JO, Gaynor M, McDermott D, Weisenburger DD, Adler K, Beshevkin M, Silver RT, Reisman AM, Pasmantier MW. Coleman M, et al. Among authors: mcdermott d. Semin Hematol. 1988 Apr;25(2 Suppl 2):23-33. Semin Hematol. 1988. PMID: 2456620

6

Inadequacy of predicted creatinine clearance as guide to chemotherapy.

McDermott DF, Galindo A, Sherman RL, Jaffe EA, Coleman M, Pasmantier MW. McDermott DF, et al. Cancer Treat Rep. 1987 Nov;71(11):1067-9. Cancer Treat Rep. 1987. PMID: 3677111

7

Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.

Murray HW, Hariprashad J, McDermott DF, Stoeckle MY. Murray HW, et al. Among authors: mcdermott df. Infect Immun. 1996 Jan;64(1):161-6. doi: 10.1128/iai.64.1.161-166.1996. Infect Immun. 1996. PMID: 8557335 Free PMC article.

8

Role and effect of IL-2 in experimental visceral leishmaniasis.

Murray HW, Miralles GD, Stoeckle MY, McDermott DF. Murray HW, et al. Among authors: mcdermott df. J Immunol. 1993 Jul 15;151(2):929-38. J Immunol. 1993. PMID: 8335921

9

Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis.

Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW. Miralles GD, et al. Among authors: mcdermott df. Infect Immun. 1994 Mar;62(3):1058-63. doi: 10.1128/iai.62.3.1058-1063.1994. Infect Immun. 1994. PMID: 8112840 Free PMC article.

10

Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.

Xu W, Birch G, Meliki A, Moritz V, Bharadwaj M, Schindler NR, Labaki C, Saliby RM, Dinh K, Horst JT, Sun M, Kashima S, Hugaboom M, Dighe A, Machaalani M, Lee GM, Hurwitz M, McGregor BA, Hirsch MS, Shukla SA, McDermott DF, Signoretti S, Romee R, Choueiri TK, Braun DA. Xu W, et al. Among authors: mcdermott df. ESMO Open. 2025 Jan 14;10(2):104105. doi: 10.1016/j.esmoop.2024.104105. Online ahead of print. ESMO Open. 2025. PMID: 39813824 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

690 results

Search Page

Filters